Randall Bender
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Randall Bender has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Lauren Nelson
Patient-Centered Outcomes Assessment, RTI Health Solutions (RTI-HS), Research Triangle Park, USA
3 shared publications - Kathleen W. Wyrwich
Patient-Centered Outcomes Assessment, Pfizer, New York, USA
2 shared publications - Kavita Gandhi
Johnson and Johnson, Raritan, USA
2 shared publications - Lori Davis McLeod
RTI Health Solutions, Research Triangle Park, NC, USA
2 shared publications - Nicole Williams
ICF International, Reston, USA
2 shared publications - Nimanee Harris
Patient-Centered Outcomes Assessment, RTI Health Solutions (RTI-HS), Research Triangle Park, USA
2 shared publications
Latest Publications
- Open Access
- 5 August 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 193 (6) , 1155-1164
The Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient-reported outcomes for hidradenitis suppurativa
Background: Hidradenitis suppurativa (HS) is associated with a substantial disease burden. Given the complex nature of HS-related symptoms, patient-reported outcome (PRO) measures are important to ensure that the patient experience is captured when evaluating the efficacy of treatments in clinical trials. Objectives: To develop the Hidradenitis Suppurativa Symptom and Impact Diary (HSSID©), a novel PRO measure for use in clinical trials to assess the symptoms and impacts of HS in adult patients, and to validate its psychometric properties. Methods: The development phase involved patients with HS and clinicians with HS expertise and included three sequential stages: (i) concept elicitation interviews (n = 8); (ii) item development; and (iii) cognitive debriefing interviews (n = 12). The psychometric properties of the HSSID were evaluated using data from a subset of patients participating in the SUNSHINE (NCT03713619) and SUNRISE (NCT03713632) trials, and included assessments of reliability, validity and ability to detect change. Anchor-based methods to estimate meaningful change thresholds were explored. Results: The HSSID comprises 11 items; 5 relate to HS symptoms (lesion-related pain, lesion-related itching, lesion drainage, odour and physical fatigue) and 6 to HS impacts (ability to walk, ability to move [other than walking], sleep disturbance, time spent with other people, negative impact on emotions and ability to complete work). Patients found the HSSID items easy to understand and reported no difficulties recalling symptoms/impacts experienced in the previous 24 h. Overall, 478 patients from SUNSHINE and SUNRISE were included in the psychometric evaluation phase. Good association with low redundancy was observed among HSSID items with moderate (> 0.30) to strong (> 0.50) inter-diary item correlations among symptoms and impact items, and across groups. Test–retest reliability estimates in stable subsets were high across SUNSHINE and SUNRISE, ranging from 0.78 to 0.96. Construct validity analysis confirmed that each HSSID item correlated with ≥ 1 targeted support variable. HSSID item scores demonstrated satisfactory responsiveness to detect change; however, anchor-based meaningful change thresholds could be established for the worst lesion-related pain item only. Conclusions: The HSSID appropriately assesses the symptoms and impacts of HS in adults. HSSID items demonstrated generally robust psychometric properties.
- 5 August 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 193 (6) , 1155-1164
Open AccessThe Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient-reported outcomes for hidradenitis suppurativa
Background: Hidradenitis suppurativa (HS) is associated with a substantial disease burden. Given the complex nature of HS-related symptoms, patient-reported outcome (PRO) measures are important to ensure that the patient experience is captured when evaluating the efficacy of treatments in clinical trials. Objectives: To develop the Hidradenitis Suppurativa Symptom and Impact Diary (HSSID©), a novel PRO measure for use in clinical trials to assess the symptoms and impacts of HS in adult patients, and to validate its psychometric properties. Methods: The development phase involved patients with HS and clinicians with HS expertise and included three sequential stages: (i) concept elicitation interviews (n = 8); (ii) item development; and (iii) cognitive debriefing interviews (n = 12). The psychometric properties of the HSSID were evaluated using data from a subset of patients participating in the SUNSHINE (NCT03713619) and SUNRISE (NCT03713632) trials, and included assessments of reliability, validity and ability to detect change. Anchor-based methods to estimate meaningful change thresholds were explored. Results: The HSSID comprises 11 items; 5 relate to HS symptoms (lesion-related pain, lesion-related itching, lesion drainage, odour and physical fatigue) and 6 to HS impacts (ability to walk, ability to move [other than walking], sleep disturbance, time spent with other people, negative impact on emotions and ability to complete work). Patients found the HSSID items easy to understand and reported no difficulties recalling symptoms/impacts experienced in the previous 24 h. Overall, 478 patients from SUNSHINE and SUNRISE were included in the psychometric evaluation phase. Good association with low redundancy was observed among HSSID items with moderate (> 0.30) to strong (> 0.50) inter-diary item correlations among symptoms and impact items, and across groups. Test–retest reliability estimates in stable subsets were high across SUNSHINE and SUNRISE, ranging from 0.78 to 0.96. Construct validity analysis confirmed that each HSSID item correlated with ≥ 1 targeted support variable. HSSID item scores demonstrated satisfactory responsiveness to detect change; however, anchor-based meaningful change thresholds could be established for the worst lesion-related pain item only. Conclusions: The HSSID appropriately assesses the symptoms and impacts of HS in adults. HSSID items demonstrated generally robust psychometric properties.
- 13 November 2022
- Published by Springer Nature in Quality of Life Research
- Vol. 32 (5) , 1277-1293
Comparison of anchor-based methods for estimating thresholds of meaningful within-patient change using simulated PROMIS PF 20a data under various joint distribution characteristic conditions
Purpose To compare the performance of anchor-based methods for estimating thresholds of meaningful within-patient change (i.e., individual change) of clinical outcome assessments in conditions reflecting data characteristics of small- to medium-sized clinical trials. Methods Datasets were generated from the joint distributions of the PROMIS PF 20a T-score changes and a seven-point global change anchor measure. The 108 simulation conditions (1000 replications per condition) included combinations of three marginal distributions of T-score changes, three improvement percentages in the anchor measure, four levels of responsiveness correlations, and three sample sizes. Threshold estimation methods included mean change, median change, ROC curve, predictive modeling, half SD, and SEM. Relative bias, precision, accuracy, and measurement significance of the estimates were evaluated based on comparison with true thresholds and IRT-based individual reliable changes of PROMIS scores. Quantile regression models were applied to select and interpret effects of simulation conditions on estimation bias. Results When PROMIS T-score changes were distributed normally, the predictive modeling method performed best with 50% or more responders identified by the anchor; the mean and median methods were preferred with 30% responders. For skewed distributions, the median method and ROC method gained more advantages. Among the evaluated study conditions, the improvement percentage condition had the most obvious effects on estimation bias. Conclusion To establish accurate and precise thresholds, clinical researchers are recommended to prioritize study designs with at least 50% anchor-defined responders and strongly responsive target endpoints with highly reliable scoring calibration and to select optimal anchor-based methods given the data characteristics.
- 13 November 2022
- Published by Springer Nature in Quality of Life Research
- Vol. 32 (5) , 1277-1293
Comparison of anchor-based methods for estimating thresholds of meaningful within-patient change using simulated PROMIS PF 20a data under various joint distribution characteristic conditions
Purpose To compare the performance of anchor-based methods for estimating thresholds of meaningful within-patient change (i.e., individual change) of clinical outcome assessments in conditions reflecting data characteristics of small- to medium-sized clinical trials. Methods Datasets were generated from the joint distributions of the PROMIS PF 20a T-score changes and a seven-point global change anchor measure. The 108 simulation conditions (1000 replications per condition) included combinations of three marginal distributions of T-score changes, three improvement percentages in the anchor measure, four levels of responsiveness correlations, and three sample sizes. Threshold estimation methods included mean change, median change, ROC curve, predictive modeling, half SD, and SEM. Relative bias, precision, accuracy, and measurement significance of the estimates were evaluated based on comparison with true thresholds and IRT-based individual reliable changes of PROMIS scores. Quantile regression models were applied to select and interpret effects of simulation conditions on estimation bias. Results When PROMIS T-score changes were distributed normally, the predictive modeling method performed best with 50% or more responders identified by the anchor; the mean and median methods were preferred with 30% responders. For skewed distributions, the median method and ROC method gained more advantages. Among the evaluated study conditions, the improvement percentage condition had the most obvious effects on estimation bias. Conclusion To establish accurate and precise thresholds, clinical researchers are recommended to prioritize study designs with at least 50% anchor-defined responders and strongly responsive target endpoints with highly reliable scoring calibration and to select optimal anchor-based methods given the data characteristics.
- Open Access
- 10 April 2022
- Published by Springer Nature in Dermatology and Therapy
- Vol. 12 (5) , 1287
Correction to: Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
- 10 April 2022
- Published by Springer Nature in Dermatology and Therapy
- Vol. 12 (5) , 1287
Open AccessCorrection to: Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
- Open Access
- 30 November 2021
- Published by Springer Nature in Dermatology and Therapy
- Vol. 12 (1) , 149-166
Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
Introduction Individuals with alopecia areata (AA) may experience significant impacts on their health-related quality of life. The novel Alopecia Areata Patient Priority Outcomes (AAPPO) questionnaire has been developed to assess hair loss signs, emotional symptoms, and activity limitations associated with AA. The objective of this study was to evaluate psychometric properties and establish scoring of the AAPPO in adults and adolescents with AA. Methods Scoring and measurement properties of the AAPPO were examined using baseline and 2-week follow-up data from a prospective, noninterventional, web-based study of 121 patients with AA (85 adults aged ≥ 18 years, 36 adolescents aged 12–17 years) with Severity of Alopecia Tool (SALT) ≥ 25% scalp hair loss. Results Exploratory and confirmatory factor analysis supported four single Hair Loss (HL) items, an Emotional Symptoms domain (ES; 4 items), and an Activity Limitations domain (AL; 3 items). Among all patients, the multi-item ES and AL domains had strong internal consistency (α ≥ 0.87); all HL items and domain scores had strong test-retest reliability (weighted kappa or intraclass correlation coefficients ≥ 0.78). All HL item scores demonstrated strong construct validity (r ≥ 0.52) compared with the patient-reported Alopecia Areata Symptom and Impact Scale (AASIS) hair loss subscale score; ES and AL domain scores exhibited strong construct validity (r ≥ 0.66) compared with the SF-36 Mental Component Summary (MCS) score. Using SALT scores, HL mean item scores were better (lower) in the 25–49% SALT subgroup versus those with highest SALT scores (76–100%); however, ES mean domain scores were better in the SALT 76–100% subgroup in the same comparison (p < 0.0001). Using AASIS and MCS score–created subgroups, ES and AL mean domain scores demonstrated hypothesized differences across subgroups (all p values < 0.0001). Conclusion The AAPPO questionnaire is a reliable, valid disease-specific measure of hair loss severity and impact in individuals with AA.
- 30 November 2021
- Published by Springer Nature in Dermatology and Therapy
- Vol. 12 (1) , 149-166
Open AccessValidation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
Introduction Individuals with alopecia areata (AA) may experience significant impacts on their health-related quality of life. The novel Alopecia Areata Patient Priority Outcomes (AAPPO) questionnaire has been developed to assess hair loss signs, emotional symptoms, and activity limitations associated with AA. The objective of this study was to evaluate psychometric properties and establish scoring of the AAPPO in adults and adolescents with AA. Methods Scoring and measurement properties of the AAPPO were examined using baseline and 2-week follow-up data from a prospective, noninterventional, web-based study of 121 patients with AA (85 adults aged ≥ 18 years, 36 adolescents aged 12–17 years) with Severity of Alopecia Tool (SALT) ≥ 25% scalp hair loss. Results Exploratory and confirmatory factor analysis supported four single Hair Loss (HL) items, an Emotional Symptoms domain (ES; 4 items), and an Activity Limitations domain (AL; 3 items). Among all patients, the multi-item ES and AL domains had strong internal consistency (α ≥ 0.87); all HL items and domain scores had strong test-retest reliability (weighted kappa or intraclass correlation coefficients ≥ 0.78). All HL item scores demonstrated strong construct validity (r ≥ 0.52) compared with the patient-reported Alopecia Areata Symptom and Impact Scale (AASIS) hair loss subscale score; ES and AL domain scores exhibited strong construct validity (r ≥ 0.66) compared with the SF-36 Mental Component Summary (MCS) score. Using SALT scores, HL mean item scores were better (lower) in the 25–49% SALT subgroup versus those with highest SALT scores (76–100%); however, ES mean domain scores were better in the SALT 76–100% subgroup in the same comparison (p < 0.0001). Using AASIS and MCS score–created subgroups, ES and AL mean domain scores demonstrated hypothesized differences across subgroups (all p values < 0.0001). Conclusion The AAPPO questionnaire is a reliable, valid disease-specific measure of hair loss severity and impact in individuals with AA.
- 1 May 2015
- Published by Elsevier in Value in Health
- Vol. 18 (3) , A208
Mapping Utility Scores from European organization for Treatment of Cancer Core-30 Questionnaire Scores (Eortc Qlq-C30) In Relapsed Multiple Myeloma
- 1 May 2015
- Published by Elsevier in Value in Health
- Vol. 18 (3) , A208
Mapping Utility Scores from European organization for Treatment of Cancer Core-30 Questionnaire Scores (Eortc Qlq-C30) In Relapsed Multiple Myeloma
- Open Access
- 1 March 2012
- Published by Alcohol Research Documentation, Inc. in Journal of Studies on Alcohol and Drugs
- Vol. 73 (2) , 226-237
Cost-Effectiveness Analysis of Motivational Interviewing With Feedback to Reduce Drinking Among a Sample of College Students
Objective:This study evaluated the costs and cost-effectiveness of combining motivational interviewing with feedback to address heavy drinking among university freshmen.Method:Microcosting methods ...
- 1 March 2012
- Published by Alcohol Research Documentation, Inc. in Journal of Studies on Alcohol and Drugs
- Vol. 73 (2) , 226-237
Open AccessCost-Effectiveness Analysis of Motivational Interviewing With Feedback to Reduce Drinking Among a Sample of College Students
Objective:This study evaluated the costs and cost-effectiveness of combining motivational interviewing with feedback to address heavy drinking among university freshmen.Method:Microcosting methods ...